123 related articles for article (PubMed ID: 21615487)
1. Lower circulating levels of complement split proteins C3a and C4a in maternal plasma of women with gestational diabetes mellitus.
Lappas M
Diabet Med; 2011 Aug; 28(8):906-11. PubMed ID: 21615487
[TBL] [Abstract][Full Text] [Related]
2. Anaphylatoxins in preterm and term labor.
Soto E; Romero R; Richani K; Espinoza J; Nien JK; Chaiworapongsa T; Santolaya-Forgas J; Edwin SS; Mazor M
J Perinat Med; 2005; 33(4):306-13. PubMed ID: 16207115
[TBL] [Abstract][Full Text] [Related]
3. Unexplained intrauterine fetal death is accompanied by activation of complement.
Richani K; Romero R; Soto E; Espinoza J; Nien JK; Chaiworapongsa T; Refuerzo J; Blackwell S; Edwin SS; Santolaya-Forgas J; Mazor M
J Perinat Med; 2005; 33(4):296-305. PubMed ID: 16207114
[TBL] [Abstract][Full Text] [Related]
4. Anaphylatoxin levels in human aqueous humor.
Mondino BJ; Sumner H
Invest Ophthalmol Vis Sci; 1986 Aug; 27(8):1288-92. PubMed ID: 3488296
[TBL] [Abstract][Full Text] [Related]
5. Plasma levels and mode of excretion of the anaphylatoxins C3a and C4a in renal disease.
Abou-Ragheb HH; Williams AJ; Brown CB; Milford-Ward A
J Clin Lab Immunol; 1991 Jul; 35(3):113-9. PubMed ID: 1668764
[TBL] [Abstract][Full Text] [Related]
6. Early plasma complement C3a levels correlate with functional outcome after aneurysmal subarachnoid hemorrhage.
Mack WJ; Ducruet AF; Hickman ZL; Garrett MC; Albert EJ; Kellner CP; Mocco J; Connolly ES
Neurosurgery; 2007 Aug; 61(2):255-60; discussion 260-1. PubMed ID: 17762737
[TBL] [Abstract][Full Text] [Related]
7. [Atopic dermatitis. II. The status of complement proteins and the pathogenetic role of anaphylatoxins C4a, C3a and C5a].
Sergeev IuV; Reznikov IuP; Lobanova EV; Pimenova NS
Vestn Dermatol Venerol; 1989; (4):4-7. PubMed ID: 2788339
[TBL] [Abstract][Full Text] [Related]
8. Generation of human C3a, C4a, and C5a anaphylatoxins by protein A of Staphylococcus aureus and immobilized protein A reagents used in serotherapy of cancer.
Langone JJ; Das C; Bennett D; Terman DS
J Immunol; 1984 Aug; 133(2):1057-63. PubMed ID: 6610702
[TBL] [Abstract][Full Text] [Related]
9. [Immunological tests: Anaphylatoxins C3a, C4a, C5a].
Fujino S; Sakurabayashi I
Nihon Rinsho; 2005 Jul; 63 Suppl 7():80-3. PubMed ID: 16111194
[No Abstract] [Full Text] [Related]
10. Complement activation in diabetic ketoacidosis and its treatment.
Jerath RS; Burek CL; Hoffman WH; Passmore GG
Clin Immunol; 2005 Jul; 116(1):11-7. PubMed ID: 15925827
[TBL] [Abstract][Full Text] [Related]
11. Anaphylatoxin levels in human vitreous humor.
Mondino BJ; Sidikaro Y; Sumner H
Invest Ophthalmol Vis Sci; 1988 Jul; 29(7):1195-8. PubMed ID: 3262096
[TBL] [Abstract][Full Text] [Related]
12. Alterations in systemic complement component 3a and 5a levels in patients with cerebral arteriovenous malformations.
Haque R; Hwang BY; Appelboom G; Piazza MA; Guo K; Connolly ES
J Clin Neurosci; 2011 Sep; 18(9):1235-9. PubMed ID: 21742500
[TBL] [Abstract][Full Text] [Related]
13. Release of anaphylatoxins during orthotopic liver transplantation.
Henriksson BA; Stenqvist O; Bengtsson JP; Bengtsson A
Transplant Proc; 1991 Jun; 23(3):1949-50. PubMed ID: 2063439
[No Abstract] [Full Text] [Related]
14. Complement mediated inhibition of immune precipitation and solubilization generate different concentrations of complement anaphylatoxins (C4a, C3a, C5a).
Schifferli JA; Steiger G; Paccaud JP
Clin Exp Immunol; 1986 May; 64(2):407-14. PubMed ID: 3488858
[TBL] [Abstract][Full Text] [Related]
15. Normal pregnancy is characterized by systemic activation of the complement system.
Richani K; Soto E; Romero R; Espinoza J; Chaiworapongsa T; Nien JK; Edwin S; Kim YM; Hong JS; Mazor M
J Matern Fetal Neonatal Med; 2005 Apr; 17(4):239-45. PubMed ID: 16147832
[TBL] [Abstract][Full Text] [Related]
16. Complement factors c3a, c4a, and c5a in chronic obstructive pulmonary disease and asthma.
Marc MM; Korosec P; Kosnik M; Kern I; Flezar M; Suskovic S; Sorli J
Am J Respir Cell Mol Biol; 2004 Aug; 31(2):216-9. PubMed ID: 15039137
[TBL] [Abstract][Full Text] [Related]
17. Plasma lactoferrin reflects granulocyte activation via complement in burn patients.
Wolach B; Coates TD; Hugli TE; Baehner RL; Boxer LA
J Lab Clin Med; 1984 Feb; 103(2):284-93. PubMed ID: 6607301
[TBL] [Abstract][Full Text] [Related]
18. Complement split products C3a and C4a are early markers of acute lyme disease in tick bite patients in the United States.
Shoemaker RC; Giclas PC; Crowder C; House D; Glovsky MM
Int Arch Allergy Immunol; 2008; 146(3):255-61. PubMed ID: 18270493
[TBL] [Abstract][Full Text] [Related]
19. Complement activation in patients with primary antiphospholipid syndrome.
Oku K; Atsumi T; Bohgaki M; Amengual O; Kataoka H; Horita T; Yasuda S; Koike T
Ann Rheum Dis; 2009 Jun; 68(6):1030-5. PubMed ID: 18625630
[TBL] [Abstract][Full Text] [Related]
20. Preservation of antimicrobial properties of complement peptide C3a, from invertebrates to humans.
Pasupuleti M; Walse B; Nordahl EA; Mörgelin M; Malmsten M; Schmidtchen A
J Biol Chem; 2007 Jan; 282(4):2520-8. PubMed ID: 17132627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
